Clinical Trial Update: Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia [NA]

View source ↗

Summary

A prospective study evaluating antiplatelet and anticoagulation therapy for hereditary hemorrhagic telangiectasia is currently recruiting, sponsored by Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease | NA | Status: RECRUITING